Clinical trial on safety of robotic gastrectomy using a da Vinci surgical system for resectable gastric cancer

Clinical trial on safety of robotic gastrectomy using a da Vinci surgical system for resectable gastric cancer - Robotic gastrectomy for gastric cancer

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027969

Enrollment

Registered

2017-07-01

Start date

2017-05-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Resectable gastric cancer

Interventions

Robotic gastrectomy using a da Vinci surgical system

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Histologically giagnosed gastric adenocarcinoma (2) Patients with resectable gastric cancers (3) For patient participation, written consent has been obtained from the patient

Exclusion criteria

Exclusion criteria: (1) Possible pregnancy (2) Patients with mental disorders (3) Patients having a history of myocardial infarction within 6 months or unstable angina (4) Hypertension with poor control (5) Combined respiratory diseases requiring sustained oxygen therapy (6) Patients that the doctors judged in appropriate.

Design outcomes

Primary

Measure	Time frame
Postoperative complications more than Clavien-Dindo Grade II	—

Secondary

Measure	Time frame
Surgical outcomes Postoperative courses Disease free survival	—

Countries

Japan

Contacts

Public ContactToshiyasu Ojima

Wakayama Medical University, School of Medicine Second Department of Surgery

tojima@wakayama-med.ac.jp073-441-0613

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026